Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 2993.

https://doi.org/10.1182/blood-2023-186530

Published: 2023

Journal Articles

DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS

Blood (2022) 140 (11): 1278–1290.

https://doi.org/10.1182/blood.2021015019

Published: 2022

Includes: Supplemental data

Journal Articles

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

Francesco d'Amore, MD, Sirpa Leppä, MD, Maria Gomes da Silva, MD PhD, Thomas Relander, Grete Fossum Lauritzsen, Peter De Nully Brown, Antonio Pezzutto, Jeanette K. Doorduijn, MD PhD, Eckhart Weidmann, Michel van Gelder, Achiel Van Hoof, Ilse Christiansen, Unn Merete Fagerli, MD PhD, Hans Hagberg, MD, P.J. Lugtenburg, Jan Walewski, Ka Lung Wu, Hilde Maria Demuynck, Rob Fijnheer, Jacob H. Christensen, Milada Jankovská, MD, Pär L. Josefsson, Hanneke Kluin-Nelemans, Jose Mario Mariz, MD, Mats A. Merup, Thomas Noesslinger, Eric Van Den Neste, Josée M Zijlstra, MD, Georg Hopfinger, MD, VIT Prochazka, MD, Esa Jantunen, MD PhD, Ludmila Boudova, Jose Cabecadas, Andreas Chott, Jan M.A. Delabie, MD PhD, Laurence de Leval, MD, Arjan Diepstra, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Peter Noergaard, Andreas Rosenwald, Grzegorz Rymkiewicz, Christer Sundström, Lorenz Truemper, MD, Gerald Wulf, MD, Lauren Chong, MSc, Alyssa Bouska, PhD, Lynette Smith, Christian Gisselbrecht, Marita Ziepert, PhD, Markus Loeffler, MD, Knut Liestol, Christian Steidl, MD, Randy D. Gascoyne, MD, David W. Scott, PhDMD,FRACP,FRCPA, Bettina Altmann, PhD, Javeed Iqbal, §, Wing C Chan, MD, Helle Toldbod, MS,PhD

Blood (2018) 132 (Supplement 1): 998.

https://doi.org/10.1182/blood-2018-99-110429

Published: 2018

Journal Articles

Tolerability and Efficacy of Treatments in Elderly Patients with Hodgkin Lymphoma: A Report from the Nebraska Lymphoma Study Group

Roberto A. Ferro, MD, Vijaya R. Bhatt, MD, Martin Bast, BS, Lynette Smith, MS, R. Gregory Bociek, MD, Matthew A. Lunning, DO, Philip J Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD

Blood (2015) 126 (23): 1504.

https://doi.org/10.1182/blood.V126.23.1504.1504

Published: 2015

Journal Articles

IDH2 R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

Blood (2015) 126 (15): 1741–1752.

https://doi.org/10.1182/blood-2015-05-644591

Published: 2015

Includes: Supplemental data

Journal Articles

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

Blood (2014) 123 (19): 2915–2923.

https://doi.org/10.1182/blood-2013-11-536359

Published: 2014

Includes: Supplemental data

Journal Articles

Gene Expression Signatures That Delineate Biologic and Prognostic Subgroups in Peripheral T-Cell Lymphoma

Blood (2012) 120 (21): 679.

https://doi.org/10.1182/blood.V120.21.679.679

Published: 2012

Journal Articles

Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling

Blood (2012) 119 (16): 3757–3766.

https://doi.org/10.1182/blood-2011-05-349662

Published: 2012

Includes: Supplemental data

Journal Articles

The Efficacy of Rasburicase and Rituximab Combined with FAB Chemotherapy in Children and Adolescents with Newly Diagnosed Stage III/IV, BM+ and CNS+ Mature B-NHL: A Children's Oncology Group Report

Stanton Goldman, MD, Paul J. Galardy, MD, Lynette Smith, MS, Sherrie L. Perkins, MD, PhD, Bruce Shiramizu, MD, Thomas Gross, MD, PhD, Warren G. Sanger, PhD, Lauren Harrison, RN, MSN, Mitchell S. Cairo, MD

Blood (2011) 118 (21): 2702.

https://doi.org/10.1182/blood.V118.21.2702.2702

Published: 2011

Journal Articles

The Autoantibody Response to ALK In Pediatric Anaplastic Large Cell Lymphoma: A Children's Oncology Group Report

Megan S. Lim, MD, PhD, Karen Pulford, PhD, FRCPath, Kamel Ait-Tahar, PhD, Suketu D. Patel, MSc, Marsha C. Kinney, MD, Sherrie L. Perkins, MD, PhD, James R. Anderson, PhD, Lynette Smith, MS, Mitchell S. Cairo, MD, Sheila Weitzman, MB, Thomas G. Gross, MD, PhD, Jacqueline M. Kraveka, DO

Blood (2010) 116 (21): 4130.

https://doi.org/10.1182/blood.V116.21.4130.4130

Published: 2010

Journal Articles

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

Blood (2010) 115 (5): 1026–1036.

https://doi.org/10.1182/blood-2009-06-227579

Published: 2010

Includes: Supplemental data

Journal Articles

Mutations in the DNA-binding codons of TP53 , which are associated with decreased expression of TRAIL receptor-2, predict for poor survival in diffuse large B-cell lymphoma

Ken H. Young, Dennis D. Weisenburger, Bhavana J. Dave, Lynette Smith, Warren Sanger, Javeed Iqbal, Elias Campo, Jan Delabie, Randy D. Gascoyne, German Ott, Lisa Rimsza, H. Konrad Müller-Hermelink, Elaine S. Jaffe, Andreas Rosenwald, Louis M. Staudt, Wing C. Chan, Timothy C. Greiner

Blood (2007) 110 (13): 4396–4405.

https://doi.org/10.1182/blood-2007-02-072082

Published: 2007

Includes: Supplemental data

NARROW

Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma

DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

Tolerability and Efficacy of Treatments in Elderly Patients with Hodgkin Lymphoma: A Report from the Nebraska Lymphoma Study Group

IDH2 R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

Gene Expression Signatures That Delineate Biologic and Prognostic Subgroups in Peripheral T-Cell Lymphoma

Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling

The Efficacy of Rasburicase and Rituximab Combined with FAB Chemotherapy in Children and Adolescents with Newly Diagnosed Stage III/IV, BM+ and CNS+ Mature B-NHL: A Children's Oncology Group Report

The Autoantibody Response to ALK In Pediatric Anaplastic Large Cell Lymphoma: A Children's Oncology Group Report

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

Mutations in the DNA-binding codons of TP53 , which are associated with decreased expression of TRAIL receptor-2, predict for poor survival in diffuse large B-cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only